Skip to main content
. 2022 Jan 29;11(2):887–897. doi: 10.1007/s40123-022-00466-2
The AutoInflammatory Disease Alliance (AIDA) International Registry for non-infectious scleritis is available and ready for data collection.
The registry will allow the scientific community to communicate, share information and actively participate in research projects.
Implementation and execution of a large international registry will overcome limitations owing to the low epidemiological burden of non-infectious scleritis.
Future solid evidence drawn from a wide range of standardised real-world data will corroborate results obtained from the few randomised clinical trials currently available.